Fotios Plakogiannis
Fondateur chez Transdermal Research Pharm Laboratories LLC
Postes actifs de Fotios Plakogiannis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Transdermal Research Pharm Laboratories LLC | Fondateur | 01/01/2013 | - |
| President | 01/01/2013 | - | |
ChemioCare, Inc.
 ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Fotios Plakogiannis
Anciens postes connus de Fotios Plakogiannis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AEQUUS PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 03/01/2014 | 10/07/2018 |
| Président | 25/02/2013 | 10/12/2014 | |
| Fondateur | 03/01/2013 | 10/07/2018 | |
| Long Island University | Corporate Officer/Principal | 01/01/1967 | 01/01/2011 |
| Arnold & Marie Schwartz College of Pharmacy & Health Science | Corporate Officer/Principal | - | - |
Formation de Fotios Plakogiannis
| The Ohio State University | Graduate Degree |
| University of Southern California | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AEQUUS PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Transdermal Research Pharm Laboratories LLC | |
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | Health Technology |
- Bourse
- Insiders
- Fotios Plakogiannis
- Expérience
